Mass Spectra of Designer Drugs 2020

Developed to help combat the global opioid health epidemic

The Mass Spectra of Designer Drugs 2020 is the largest collection of chemical signatures of NPS and drugs of abuse in the world. The 2020 edition features the addition of over 1,300 new mass spectra and over 700 new, unique compounds in over 30 different classification groups such as fentanyls, synthetic cannabinoids, and opiates.

With an average quality index per spectrum of 951.0 and 18,793 Kovats retention indices, this spectral library provides comprehensive data on the most up-to-date list of novel psychoactive substances. Updated annually, the 2020 edition covers the range of known novel psychoactive substances through December 31, 2019.

For more information, visit https://sciencesolutions.wiley.com/solutions/technique/gc-ms/mass-spectra-of-designer-drugs/